In stock
KLOW Blend: A research formulation designed to study the convergent effects of BPC 157 (10mg), TB 500 (10mg), KPV (10mg), and GHK-Cu (50mg).
$325.00
In stock
KLOW Blend is a multi component research formulation that combines four well characterized peptides
BPC 157
TB 500 Thymosin Beta 4
Ac KPV NH2
GHK Cu tripeptide copper complex
It is supplied as a research grade mixture for laboratories that want to study convergent mechanisms of tissue protection inflammation control and regenerative signaling using a single consolidated preparation.
Each constituent peptide has been investigated independently in preclinical models BPC 157 in gastrointestinal tissue integrity and wound related research
TB 500 Thymosin Beta 4 in actin cytoskeleton regulation cell migration and tissue repair research Ac KPV NH2 in inflammatory signaling epithelial transport and cytokine associated pathways research GHK Cu in fibroblast behavior extracellular matrix biology angiogenesis and copper dependent signaling research Although there is thematic overlap in areas such as cytoprotection immune modulation angiogenic support and matrix remodeling the peptides act through distinct molecular targets and pathways. Combining them in a single formulation allows researchers to examine how these pathways interact in complex tissue environments and whether layered signaling produces additive or synergistic effects on healing kinetics tissue architecture and functional recovery in model systems. This blend is intended to simplify multi arm experimental designs where the alternative would be separate preparation and administration of each peptide. By consolidating four agents into one vial laboratories can shift emphasis toward mechanistic interrogation biomarker profiling and outcome measurement while reducing logistical complexity.
KLOW Blend is intended exclusively for in vitro experiments ex vivo preparations and other controlled laboratory research applications including animal studies conducted under appropriate oversight. Typical uses include multidimensional wound healing models composite tissue injury paradigms organ specific repair studies and in vitro assays that require simultaneous exposure to multiple peptide signals.
It is not intended for human or veterinary use.
It is not intended for diagnosis treatment cure prevention or mitigation of any disease cosmetic concern or medical condition.
It is not a drug food dietary supplement cosmetic or medical device.
Four peptide formulation BPC 157 TB 500 Thymosin Beta 4 Ac KPV NH2 and GHK Cu in a single research vial
Designed for studies of combined effects on tissue repair inflammatory signaling angiogenesis and matrix remodeling
Reduces the need for separate peptide handling and dosing protocols in complex experimental designs
Manufactured under controlled conditions with analytical verification of identity and purity of individual components and blend composition
KLOW Blend combines four peptides that are each widely studied in tissue repair and inflammation models
BPC 157
TB 500 Thymosin Beta 4
Ac KPV NH2
GHK Cu
Research on this blend focuses on how these distinct pathways behave when activated together in the same system.
The aim is to understand convergence effects on healing speed tissue architecture and durability of repair under controlled conditions.
BPC 157 is used in gastrointestinal and soft tissue models that examine integrity barrier function and repair kinetics. TB 500 Thymosin Beta 4 is a core tool in cytoskeletal research and cell migration particularly where actin dynamics underpin wound closure and angiogenesis. Ac KPV NH2 is deployed in inflammatory and epithelial transport assays where investigators track cytokine networks and barrier responses. GHK Cu is a standard reagent in fibroblast and endothelial research where extracellular matrix production angiogenesis and copper dependent signaling are central. KLOW Blend enables experiments where all four signals are present at once. This allows researchers to map how growth of new vessels matrix remodeling epithelial barrier regulation and inflammatory resolution interact in the same injury model rather than in separate single peptide studies.
In advanced wound models investigators often need to account for overlapping biology hemostasis and early inflammation fibroblast recruitment and collagen deposition re epithelialisation angiogenesis and long term remodeling. Using KLOW Blend, labs can design protocols where each of these phases is exposed to a consistent multi peptide environment.
Readouts commonly include
closure rate histologic scoring of granulation tissue and collagen organisation re epithelialisation depth capillary density and pericyte coverage local cytokine and chemokine profiles. Comparisons are then made between single component arms and the KLOW combination to detect additive or cooperative effects on structure and function.
TB 500 and GHK Cu are both used independently in angiogenesis assays. With KLOW Blend, endothelial and pericyte co culture systems can be exposed to a matrix environment that also contains BPC 157 and KPV driven signals.
Typical endpoints
tube formation metrics and branching complexity
endothelial barrier resistance
expression of angiogenic factors and matrix metalloproteinases
pericyte recruitment and vessel stabilisation markers.
The goal is to see whether a multi signal environment produces vessels that are not only more numerous but also more stable and better integrated into surrounding tissue constructs.
KPV and BPC 157 are often used in models that focus on mucosal and epithelial surfaces. GHK Cu and TB 500 contribute additional inputs on fibroblast behaviour and local matrix context. In KLOW Blend experiments, researchers can explore how epithelial transporters and tight junction proteins respond under inflammatory challenge whether combined peptide exposure shifts cytokine balance and leukocyte trafficking how stromal cells remodel the extracellular matrix around epithelial layers. This is particularly useful in gut, skin and corneal models where barrier integrity, local inflammation and stromal repair need to be evaluated together.
GHK Cu and TB 500 sit at the centre of extracellular matrix and cytoskeletal research. Paired with BPC 157 and KPV, KLOW Blend allows for extended observation of how tissues remodel over longer time frames beyond initial closure.
collagen type ratios and fibre alignment scar thickness versus normal tissue mechanical strength testing in tendons or skin strips expression of remodeling associated enzymes and inhibitors. These models inform whether a multi peptide environment shifts outcomes toward more organised, functionally resilient tissue compared with standard single peptide or saline controls.
Multi arm studies that test several peptides alone and in combination quickly become complex in terms of preparation and dosing. KLOW Blend was created to reduce that complexity when the scientific question is specifically about convergence of these four signals. By consolidating them into one vial, investigators can
standardise dosing schedules more easily reduce preparation error risk allocate more resources to deep biomarker analysis and imaging. This does not replace single peptide or pairwise studies. Instead it provides a higher level tool when the objective is to test a multi pathway repair stimulus as a unified exposure condition.
Across labs KLOW Blend is suited to complex wound and surgical repair models tendon and ligament injury systems that require both angiogenesis and matrix remodeling
composite epithelial barrier plus stromal co culture setups comparative studies of mono versus multi peptide exposure in tissue regeneration workflows. In every case KLOW Blend is a platform for investigating how BPC 157, TB 500, KPV and GHK Cu behave together, not a finished therapeutic product. Important research disclaimer
All uses described here refer to controlled in vitro systems, ex vivo preparations and animal models. They are presented only to inform qualified researchers about how a multi peptide blend can be positioned for mechanistic work. These observations do not show or imply that KLOW Blend or its components are safe or effective for any human or veterinary indication. They are not dosing instructions, medical advice or guidance for cosmetic, performance or therapeutic use. KLOW Blend is intended strictly for laboratory research applications. It is not for human or veterinary use and must not be used for diagnosis, treatment, cure, prevention or mitigation of any disease or condition.
Store peptides only in professional, controlled environments that operate under their own safety and quality systems. All storage, handling, and disposal must follow your organization’s written policies, risk assessments, and standard operating procedures. It is the responsibility of the facility and its staff to ensure that these policies are in place, understood, and actively followed. Keep vials in a cool, dry location away from direct light, heat, and moisture. Vials should remain upright, sealed, and protected from physical impact so contents and labels stay intact and legible. If your procedures include freezing, use appropriate working volumes and avoid repeated freeze and thaw cycles of the same vial. Do not store peptides near food, drink, or general consumables. Keep them only in designated storage areas with controlled access that reflect your internal governance and regulatory obligations. Handling and preparation must be carried out solely by personnel who are trained and authorized under your institutional guidelines.
This product is intended exclusively for in vitro experiments ex vivo preparations and other controlled laboratory research applications including animal studies conducted under appropriate oversight.
Typical uses include cell culture assays biochemical experiments on copper binding and transport and investigations of extracellular matrix remodeling and tissue biology.
It is not intended for human or veterinary use.
It is not intended for diagnosis treatment cure prevention or mitigation of any disease or cosmetic condition.
It is not a drug food dietary supplement cosmetic ingredient or medical device.
$175.00
Glutathione 1500mg: A fundamental tripeptide reagent for investigating cellular redox buffering, antioxidant enzyme kinetics, and thiol-mediated detoxification pathways.
$145.00
GROW Blend: A dual-pathway research mixture combining CJC 1295 no DAC (5mg) and Ipamorelin (5mg).
$115.00
GHK-Cu 100mg: A tripeptide-copper complex utilized in cell culture research to study extracellular matrix remodeling, angiogenesis, and copper-dependent signaling.
$285.00
GLOW Blend: A consolidated research formulation of BPC 157 (10mg), TB 500 (10mg), and GHK-Cu (50mg).
